Washington — A federal appeals court upheld the Food and Drug Administration’s 23-year-old approval of the widely used abortion pill mifepristone, but said a series of actions the agency took in recent years to make it easier to obtain went too far. A three-judge panel from the U.S. Court of…Read More
Related Posts
Intervention boosts discussion of outofpocket HF drug costs between patients doctors
PHILADELPHIA -- Patients with HF with reduced ejection fraction who were provided information about out-of-pocket costs for medications were more likely to discuss costs with their doctors than those who…
Ohio marijuana legalization question falls short on signatures for fall ballot gets 10 more days
COLUMBUS, Ohio -- A proposal to legalize adult use of marijuana in Ohio fell short Tuesday of the signatures it needed to make the fall statewide ballot. Backers will have…
Democrats postpone a subpoena vote in the Supreme Court ethics probe after a blowup with…
WASHINGTON (AP) -- Democrats on the Senate Judiciary Committee abruptly adjourned a meeting on Thursday without holding an expected vote on subpoenas for two conservatives who have helped arrange luxury…
